Literature DB >> 34962124

Acid-Catalyzed Synthesis of Isatoic Anhydride-8-Secondary Amides Enables IASA Transformations for Medicinal Chemistry.

Sudershan R Gondi1, Althaf Shaik2, Kenneth D Westover1.   

Abstract

Quinazolin-dione-N-3-alklyl derivatives are the core scaffolds for several categories of bioactive small molecules, but current synthetic methods are costly, involve environmental hazards, and are not uniformly scalable. Here, we report an inexpensive, flexible, and scalable method for the one-pot synthesis of substituted quinazolin-dione-N-3-alkyls (isomers of isatoic-8-secondary amides (IASAs)) from isatin that take advantage of in situ capture of imidic acid under acidic conditions. We further show that this method can be used for the synthesis of a wide variety of derivatives with medicinal uses.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34962124      PMCID: PMC9107799          DOI: 10.1021/acs.joc.1c02036

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.198


  20 in total

1.  Search for new pharmacophores for antimalarial activity. Part II: synthesis and antimalarial activity of new 6-ureido-4-anilinoquinazolines.

Authors:  S Madapa; Z Tusi; A Mishra; K Srivastava; S K Pandey; R Tripathi; S K Puri; S Batra
Journal:  Bioorg Med Chem       Date:  2008-11-08       Impact factor: 3.641

2.  1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.

Authors:  Stefania Butini; Darryl S Pickering; Elena Morelli; Salvatore Sanna Coccone; Francesco Trotta; Meri De Angelis; Egeria Guarino; Isabella Fiorini; Giuseppe Campiani; Ettore Novellino; Arne Schousboe; Jeppe K Christensen; Sandra Gemma
Journal:  J Med Chem       Date:  2008-09-24       Impact factor: 7.446

3.  Development of Quinazoline/Pyrimidine-2,4(1H,3H)-diones as Agonists of Cannabinoid Receptor Type 2.

Authors:  Hai-Yan Qian; Zhi-Long Wang; You-Lu Pan; Li-Li Chen; Xin Xie; Jian-Zhong Chen
Journal:  ACS Med Chem Lett       Date:  2017-05-01       Impact factor: 4.345

4.  Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors.

Authors:  Kevin K C Liu; Xiaojun Huang; Shubha Bagrodia; Jeffrey H Chen; Samantha Greasley; Hengmiao Cheng; Shaoxian Sun; Dan Knighton; Caroline Rodgers; Kristina Rafidi; Aihua Zou; Jiezhan Xiao; Shengyong Yan
Journal:  Bioorg Med Chem Lett       Date:  2010-12-10       Impact factor: 2.823

5.  Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.

Authors:  Thomas Herget; Martina Freitag; Monika Morbitzer; Regina Kupfer; Thomas Stamminger; Manfred Marschall
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Copper(II) interactions with non-steroidal anti-inflammatory agents. III--3-Methoxyanthranilic acid as a potential *OH-inactivating ligand: a quantitative investigation of its copper handling role in vivo.

Authors:  Barbora Halova-Lajoie; Véronique Brumas; Marina M L Fiallo; Guy Berthon
Journal:  J Inorg Biochem       Date:  2006-01-26       Impact factor: 4.155

7.  Divergent Synthesis of Quinazolin-4(3H)-ones and Tryptanthrins Enabled by a tert-Butyl Hydroperoxide/K3PO4-Promoted Oxidative Cyclization of Isatins at Room Temperature.

Authors:  Feng-Cheng Jia; Zhi-Wen Zhou; Cheng Xu; Yan-Dong Wu; An-Xin Wu
Journal:  Org Lett       Date:  2016-05-26       Impact factor: 6.005

8.  Benzimidazo[1,2-c]quinazolines: a new class of antitumor compounds.

Authors:  M F Braña; J M Castellano; G Keilhauer; A Machuca; Y Martín; C Redondo; E Schlick; N Walker
Journal:  Anticancer Drug Des       Date:  1994-12

9.  Synthesis of water soluble bis-triazenoquinazolines: an unusual predicted mode of binding to the epidermal growth factor receptor tyrosine kinase.

Authors:  Anne-Laure Larroque; Brad Peori; Christopher Williams; You Qiang Fang; Qiyu Qiu; Zakaria Rachid; Bertrand J Jean-Claude
Journal:  Chem Biol Drug Des       Date:  2008-04       Impact factor: 2.817

10.  Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.

Authors:  Satoru Tamaoki; Yukinao Yamauchi; Youichi Nakano; Sayuri Sakano; Akira Asagarasu; Michitaka Sato
Journal:  J Pharmacol Exp Ther       Date:  2007-05-31       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.